- Home
- WHLR vs AZTR Comparison
WHLR vs AZTR Comparison
Compare WHLR & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- AZTR
- Stock Information
- Founded
- WHLR 2011
- AZTR 2014
- Country
- WHLR United States
- AZTR United States
- Employees
- WHLR N/A
- AZTR N/A
- Industry
- WHLR Real Estate Investment Trusts
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- AZTR Health Care
- Exchange
- WHLR Nasdaq
- AZTR Nasdaq
- Market Cap
- WHLR 4.2M
- AZTR 4.2M
- IPO Year
- WHLR 2012
- AZTR 2023
- Fundamental
- Price
- WHLR $2.39
- AZTR $0.39
- Analyst Decision
- WHLR
- AZTR Strong Buy
- Analyst Count
- WHLR 0
- AZTR 1
- Target Price
- WHLR N/A
- AZTR $4.00
- AVG Volume (30 Days)
- WHLR 133.8K
- AZTR 7.6M
- Earning Date
- WHLR 11-06-2025
- AZTR 11-14-2025
- Dividend Yield
- WHLR N/A
- AZTR N/A
- EPS Growth
- WHLR N/A
- AZTR N/A
- EPS
- WHLR N/A
- AZTR N/A
- Revenue
- WHLR $101,839,000.00
- AZTR N/A
- Revenue This Year
- WHLR N/A
- AZTR N/A
- Revenue Next Year
- WHLR N/A
- AZTR N/A
- P/E Ratio
- WHLR $0.07
- AZTR N/A
- Revenue Growth
- WHLR N/A
- AZTR N/A
- 52 Week Low
- WHLR $1.82
- AZTR $0.35
- 52 Week High
- WHLR $11,018.00
- AZTR $4.33
- Technical
- Relative Strength Index (RSI)
- WHLR 37.04
- AZTR 31.82
- Support Level
- WHLR $1.82
- AZTR $0.35
- Resistance Level
- WHLR $3.06
- AZTR $0.41
- Average True Range (ATR)
- WHLR 0.35
- AZTR 0.07
- MACD
- WHLR -0.10
- AZTR -0.01
- Stochastic Oscillator
- WHLR 27.64
- AZTR 9.30
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.